开发一种治疗性弹性酶,通过选择性杀死癌细胞来刺激抗瘤免疫力
Ravindra Gujar1, Chang Cui1, Maria Fumagalli1
1Onchilles Pharma Inc., San Diego, CA, USA.
Cell reports. Medicine
|November 8, 2025
概括
一种新的治疗性弹性酶,N17350,有效地向中性粒细胞弹性酶通路,诱导瘤回归并刺激抗瘤免疫力. 这种方法对增强癌症免疫疗法和克服治疗耐药性的有希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药物开发 药物开发
背景情况:
- 临床研究表明,联合细胞毒剂和免疫疗法是有效的.
- 需要新的治疗方法,整合细胞毒性和免疫方法.
研究的目的:
- 开发N17350,一种治疗性弹性酶,向中性粒细胞弹性酶通路.
- 评估N17350在诱导瘤回归和刺激抗瘤免疫力的有效性.
主要方法:
- 利用了30个癌细胞系,15个瘤模型和45个患者样本.
- 开发了N17350,一种治疗性弹性酶,利用链接组合基因组H1.0和H1.2.
- 在瘤内给药的N17350.
主要成果:
- N17350诱导了快速的,基因型独立的瘤回归.
- 触发免疫性癌症细胞死亡,同时保留免疫细胞.
- 激活CD8+T细胞,增强耐久反应和检查点抑制剂在耐火模型中的有效性.
结论:
- N17350证明了其作为一种新型细胞毒剂的潜力,可以刺激抗瘤免疫力.
- N17350在重复剂量和各种治疗史中保持功效.
- 支持推进N17350首次在人身上进行临床试验.
关键词:
在ELANE路径上.N17350350 没有使用过这是一种abscopal效应.细胞毒性治疗疗法弹性酶弹性酶是一种.基因组 H1 基因组 H1免疫性细胞死亡 免疫性细胞死亡免疫疗法 免疫疗法胰腺癌是一种癌症.选择性杀死癌症 选择性杀死癌症更多相关视频
08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
3.0K
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
13.4K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer Vaccines
939
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
939
